PUBLIC COMPANY
save$TBPHTheravance Biopharma, Inc.
$TBPH16.95-0.24%George Town, Grand Cayman, CA, USupdated 6h ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (4)
- Apr 1, 26grantWinningham Rick E · CHIEF EXECUTIVE OFFICER75,000 sh
- Apr 1, 26grantFarnum Rhonda · SVP, COMM & MEDICAL AFFAIRS18,750 sh
- Apr 1, 26grantSawaf Aziz · SVP & CHIEF FINANCIAL OFFICER37,500 sh
- Apr 1, 26grantGrimaud Brett A. · SVP, GEN COUNSEL AND SECRETARY37,500 sh
🐶 Hiring Signal
News
- Theravance, after clinical setbacks, agrees to $929M buyoutThe acquisition by royalty management company Zymeworks follows a "strategic review" triggered by the failure of a drug for a type of low blood pressure.biopharma_dive · 1mo ago
Data sources
last refreshed 22m ago
Found something off?
comments(0)
5-min edit window · permanent after that